Literature DB >> 26042956

Neoadjuvant chemotherapy vs primary debulking surgery for advanced ovarian cancer. What is the debate regarding the ideal treatment: approach? age? or cost?

Ritu Salani1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26042956     DOI： 10.1016/j.ajog.2015.02.004

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  1 in total

1.  Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.

Authors:  Chiara Mignogna; Nicoletta Staropoli; Cirino Botta; Carmela De Marco; Antonia Rizzuto; Michele Morelli; Annalisa Di Cello; Renato Franco; Caterina Camastra; Ivan Presta; Natalia Malara; Angela Salvino; Pierfrancesco Tassone; Pierosandro Tagliaferri; Tullio Barni; Giuseppe Donato; Anna Di Vito
Journal:  J Ovarian Res       Date:  2016-05-21       Impact factor: 4.234
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.